A Better Health for the Bush Initiative
The Hunter New England and Central Coast Primary Health Network (the PHN) has successfully secured pilot funding under the Federal Government’s Innovative Models of Care (IMOC) Program, which will see Glen Innes as a pilot site to introduce an innovative healthcare model.
We are delighted to share an initiative by the Australian Digital Health Agency that aims to enhance the digital health literacy of health care professionals, both patients and their carers. In an era where technology is transforming the healthcare landscape, healthcare professionals must guide their patients in navigating and utilising digital health tools effectively.
The aim of this research project is to evaluate the efficacy of a practice nurse-coordinated intervention - Targeting Treatable Traits in COPD to Prevent Hospitalisations (TERRACOTTA) – in the Australian primary care.
From 1 November 2023, the varicella virus recombinant vaccine, Shingrix ®, replaces Zostavax®, on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It is available for eligible people most at risk of complications from shingles (1). The program changes follow recommendations from the Pharmaceutical Benefits Advisory Committee, the Australian Technical Advisory Group on Immunisation (ATAGI) and other clinical experts (1).
NSW Ambulance has recently launched a major recruitment drive to boost capacity within the State’s Virtual Clinical Care Centre (VCCC).
Bacterial skin infections, especially impetigo, are rising concerns in Australia, with one in four Australians affected. The Faculty of Health at the University of Canberra is delving into treatment strategies, revealing gaps in effective treatments.
The aim of the study is to describe the levels of knowledge, attitudes and current practice (KAP) amongst general practitioners (GPs) and practice nurses (PNs) working in general practice, as well as community pharmacists (CPs) regarding long acting reversible contraception (LARC) and early medical abortion (EMA).
Is your practice prepared if a patient discloses DFSV or abuse? A conversation could save a life.
In 2023, the vaccine recommendations for human papillomavirus (HPV) have changed and one dose of 9vHPV vaccine is now recommended and funded for adolescents aged 12-13 years.
NSW Health has issued an alert to clinicians and the general community, highlighting that Meningococcal disease cases are above average for this time of year.